dc.date.accessioned2019-07-04T17:00:23Z
dc.date.available2019-07-04T17:00:23Z
dc.date.created2019-07-04T17:00:23Z
dc.date.issued2019
dc.identifierhttps://hdl.handle.net/20.500.12866/6900
dc.identifierhttps://doi.org/10.1186/s13054-019-2394-9
dc.description.abstractOBJECTIVES: We sought to study the association between sedation status, medications (benzodiazepines, opioids, and antipsychotics), and clinical outcomes in a resource-limited setting. DESIGN: A longitudinal study of critically ill participants on mechanical ventilation. SETTING: Five intensive care units (ICUs) in four public hospitals in Lima, Peru. PATIENTS: One thousand six hundred fifty-seven critically ill participants were assessed daily for sedation status during 28 days and vital status by day 90. RESULTS: After excluding data of participants without a Richmond Agitation Sedation Scale score and without sedation, we followed 1338 (81%) participants longitudinally for 18,645 ICU days. Deep sedation was present in 98% of participants at some point of the study and in 12,942 ICU days. Deep sedation was associated with higher mortality (interquartile odds ratio (OR) = 5.42, 4.23-6.95; p < 0.001) and a significant decrease in ventilator (- 7.27; p < 0.001), ICU (- 4.38; p < 0.001), and hospital (- 7.00; p < 0.001) free days. Agitation was also associated with higher mortality (OR = 39.9, 6.53-243, p < 0.001). The most commonly used sedatives were opioids and benzodiazepines (9259 and 8453 patient days respectively), and the latter were associated with a 41% higher mortality in participants with a higher cumulative dose (75th vs 25th percentile, interquartile OR = 1.41, 1.12-1.77; p < 0.01). The overall cumulative dose of benzodiazepines and opioids was high, 774.5 mg and 16.8 g, respectively, by day 7 and by day 28; these doses approximately doubled. Haloperidol was only used in 3% of ICU days; however, the use of it was associated with a 70% lower mortality (interquartile OR = 0.3, 0.22-0.44, p < 0.001). CONCLUSIONS: Deep sedation, agitation, and cumulative dose of benzodiazepines were all independently associated with higher 90-day mortality. Additionally, deep sedation was associated with less ventilator-, ICU-, and hospital-free days. In contrast, haloperidol was associated with lower mortality in our study.
dc.languageeng
dc.publisherBioMed Central
dc.relationCritical Care
dc.relation1466-609X
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectacute respiratory failure
dc.subjectadult
dc.subjectagitation
dc.subjectanesthesia level
dc.subjectAPACHE
dc.subjectArticle
dc.subjectartificial ventilation
dc.subjectbenzodiazepine derivative
dc.subjectclinical assessment
dc.subjectclinical outcome
dc.subjectClinical outcomes
dc.subjectcohort analysis
dc.subjectcontrolled study
dc.subjectCritical illness
dc.subjectcritically ill patient
dc.subjectdeep sedation
dc.subjectdexmedetomidine
dc.subjectdrug use
dc.subjectfemale
dc.subjectGlasgow coma scale
dc.subjecthaloperidol
dc.subjecthuman
dc.subjectintensive care unit
dc.subjectlength of stay
dc.subjectlongitudinal study
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmiddle aged
dc.subjectmortality rate
dc.subjectmortality risk
dc.subjectmulticenter study
dc.subjectnarcotic analgesic agent
dc.subjectobservational study
dc.subjectPeru
dc.subjectprevalence
dc.subjectpriority journal
dc.subjectpropofol
dc.subjectprospective study
dc.subjectpublic hospital
dc.subjectRamsay Sedation Scale
dc.subjectRichmond Agitation Sedation Scale
dc.subjectsedation
dc.subjectSedation
dc.subjectSequential Organ Failure Assessment Score
dc.subjectventilated patient
dc.titleSedation practices and clinical outcomes in mechanically ventilated patients in a prospective multicenter cohort
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución